205 related articles for article (PubMed ID: 12191510)
1. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
Bruce MP; Boyd V; Duch C; White JR
J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
[TBL] [Abstract][Full Text] [Related]
2. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods.
Falkenberg FW
Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419
[No Abstract] [Full Text] [Related]
3. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
Trebak M; Chong JM; Herlyn D; Speicher DW
J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
[TBL] [Abstract][Full Text] [Related]
4. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
[TBL] [Abstract][Full Text] [Related]
5. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
Nagel A; Koch S; Valley U; Emmrich F; Marx U
Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production.
Jackson LR; Trudel LJ; Fox JG; Lipman NS
J Immunol Methods; 1996 Feb; 189(2):217-31. PubMed ID: 8613673
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of hybridoma production by medium supplemented with murine ascitic fluid.
Stewart SS; Fuller SA
J Immunol Methods; 1989 Sep; 123(1):45-53. PubMed ID: 2794529
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
[TBL] [Abstract][Full Text] [Related]
9. Large-scale production of monoclonal antibodies in defined serum-free media in airlift bioreactors.
Petrossian A; Cortessis GP
Biotechniques; 1990 Apr; 8(4):414-22. PubMed ID: 2340179
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors.
Kunkel JP; Jan DC; Butler M; Jamieson JC
Biotechnol Prog; 2000; 16(3):462-70. PubMed ID: 10835250
[TBL] [Abstract][Full Text] [Related]
11. A rapid procedure for purifying IgM monoclonal antibodies from murine ascites using a DEAE-disk.
Burd RS; Raymond CS; Ratz CA; Dunn DL
Hybridoma; 1993 Feb; 12(1):135-42. PubMed ID: 8454300
[TBL] [Abstract][Full Text] [Related]
12. Continuous production of monoclonal antibody in a packed-bed bioreactor.
Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
[TBL] [Abstract][Full Text] [Related]
13. Production of Monoclonal Antibody That Recognizes Zika Virus and Other Flaviviruses in Serum-Free Conditions.
Conte FP; Martins RS; Cajaraville ACDRA; Nascimento HJ; Jurgilas PB; de Lima SMB; Missailidis S; Arissawa M
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):264-271. PubMed ID: 29211630
[TBL] [Abstract][Full Text] [Related]
14. Hybridoma antibody production in vitro in type II serum-free medium using Nutridoma-SP supplements. Comparisons with in vivo methods.
Federspiel G; McCullough KC; Kihm U
J Immunol Methods; 1991 Dec; 145(1-2):213-21. PubMed ID: 1765654
[TBL] [Abstract][Full Text] [Related]
15. Trends in Monoclonal Antibody Production Using Various Bioreactor Syst.
Jyothilekshmi I; Jayaprakash NS
J Microbiol Biotechnol; 2021 Mar; 31(3):349-357. PubMed ID: 32238761
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium.
Schneider YJ
J Immunol Methods; 1989 Jan; 116(1):65-77. PubMed ID: 2644356
[TBL] [Abstract][Full Text] [Related]
17. A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma.
Yang ST; Luo J; Chen C
Adv Biochem Eng Biotechnol; 2004; 87():61-96. PubMed ID: 15217104
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of monoclonal antibody production after single and combination treatment of the hybridoma cells with all-trans retinoic acid and docosahexaenoic acid: An in vitro and in vivo study.
Rokni M; Razavi AR; Shokri F; Ahmadi Kia K; Solaymani-Mohammadi F; Chahardoli R; Saboor-Yaraghi AA
Int Immunopharmacol; 2018 Jun; 59():295-300. PubMed ID: 29677631
[TBL] [Abstract][Full Text] [Related]
19. [Continuous production of anti-hepatitis B surface antigen monoclonal antibody in hollow fiber perfusion bioreactor].
Meng MH; Chen GC; Hsieh JH; Yueh Y; Chen SC; Chang TH; Tsao D
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):125-40. PubMed ID: 3072154
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the concentration of murine IgG monoclonal antibody in hybridoma supernatants and ascites in absolute units by sensitive and reliable enzyme-linked immunosorbent assays (ELISA).
Fleming JO; Pen LB
J Immunol Methods; 1988 May; 110(1):11-8. PubMed ID: 2836513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
